Cor Vasa 2006, 48(10):340-344 | DOI: 10.33678/cor.2006.111
Serum cystatin C as a long-term predictor of overall mortality.
- 1 Interní oddělení
- 2 Oddělení laboratorní medicíny, Nemocnice Šternberk p. o., Šternberk
- 3 Ústav klinické biochemie, Fakultní nemocnice Ostrava-Poruba, Ostrava
- 4 Veterinární a farmakologická fakulta, Brno, Česká republika
Background:
Renal disorders with impaired renal functions are considered a significant risk factor for increased mortality.
Methods:
In a cross-sectional retrospective study, a total of 974 individuals (506 men, 468 women) were examined and their serum creatinine and cystatin C levels were analyzed in 1997. Follow-up was 8 years with death as the end point.
Results:
Serum cystatin C values did not differ between men and women (medians 1.28 vs. 1.27 mg/l; p = 0.9). Serum cystatin C values correlated with age (r = 0.37; p < 0.01). Two hundred and sixty subjects died during follow-up. The median
cystatin C level was significantly higher in the deceased (1.54 vs. 1.21; p < 0.01). The relative risk of death of individuals in the lowest cystatin C quartile was 12% while that of individuals in the highest cystatin C quartile was 48%. The odds ratio between the lowest and highest quartiles (1 vs. 4) was 6.9. Even when adjusted for age, cystatin C levels were significantly higher in the deceased (medians: 0.0114 vs. 0.0089; p < 0.01).
Conclusion:
Individuals with increased serum cystatin C levels have been at increased risk of death over 8-year follow-up.
Keywords: Cystatin C; Mortality; Creatinine
Published: October 1, 2006 Show citation
References
- Shlipak MG, Wassel Fyr CL, Chertow GM, et al. Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. J Am Soc Nephrol 2006;17:254-61.
Go to original source...
Go to PubMed...
- Fried LF, Katz R, Sarnak MJ, et al. Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol 2005;16:3728-35.
Go to original source...
Go to PubMed...
- Larsson A, Helmersson J, Hansson LO, Basu S. Increased serum cystatin C is associated with increased mortality in elderly men. Scand J Clin Lab Invest 2005; 65:301-5.
Go to original source...
Go to PubMed...
- Ahlstrom A, Tallgren M, Peltonen S, Pettila V. Evolution and predictive power of serum cystatin C in acute renal failure. Clin Nephrol 2004;62:344-50.
Go to original source...
Go to PubMed...
- Jernberg T, Lindahl B, James S, et al. Cystatin C. A novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation 2004;19:2342-8.
Go to original source...
Go to PubMed...
- Shlipak MG, Katz R, Fried LF, et al. Cystatin-C and mortality in elderly persons with heart failure. J Am Coll Cardiol 2005;18:268-71.
Go to original source...
Go to PubMed...
- Sarnak MJ, Katz R, Stehman-Breen CO, et al. Cardiovascular Health Study. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med 2005;142:497-505.
Go to original source...
Go to PubMed...
- Grubb AO. Cystatin C - properties and use as diagnostic marker. Adv Clin Chem 2000;35: 63-9.
Go to original source...
Go to PubMed...
- Saleem M, Florkowski CM, George PM, Woltersdorf WW. Comparison of two prediction equations with radionuclide glomerular filtration rate: validation in routine use. Ann Clin Biochem 2006;43:309-13.
Go to original source...
Go to PubMed...
- Kuan Y, Hossain M, Surman J, El Nahas AM, Haylor J. GFR prediction using the MDRD and Cockcroft and Gault equations in patients with end-stage renal disease. Nephrol Dial Transplant 2005;20:2394-401.
Go to original source...
Go to PubMed...
- Schannwell CM. Cardiac alterations caused by renal failure. Med Klin 2006;22 (Suppl I):69-71.
- Brunini TM, da Silva CD, Siqueira MA, Moss MB, Santos SF, Mendes-Ribeiro AC. Uremia, atherothrombosis and malnutrition: the role of L-arginine-nitric oxide pathway. Cardiovasc Hematol Disord Drug Targets 2006; 6:133-40.
Go to original source...
Go to PubMed...
- Kalousova M, Zima T, Tesar V, Dusilova-Sulkova S, Skrha J. Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. Mutat Res 2005;579:37-46.
Go to original source...
Go to PubMed...